Afya (AFYA)
(Delayed Data from NSDQ)
$18.17 USD
0.00 (0.00%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $18.19 +0.02 (0.11%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth B Momentum A VGM
Income Statements
Fiscal Year end for Afya Limited falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 576 | 451 | 319 | 233 | 190 |
Cost Of Goods | 222 | 167 | 121 | 84 | 78 |
Gross Profit | 354 | 285 | 198 | 149 | 112 |
Selling & Adminstrative & Depr. & Amort Expenses | 200 | 156 | 116 | 78 | 60 |
Income After Depreciation & Amortization | 154 | 129 | 82 | 70 | 52 |
Non-Operating Income | 24 | 22 | 14 | 14 | 14 |
Interest Expense | 92 | 68 | 45 | 19 | 18 |
Pretax Income | 86 | 83 | 51 | 65 | 47 |
Income Taxes | 5 | 7 | 6 | 5 | 4 |
Minority Interest | 4 | 4 | 4 | 3 | 5 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 81 | 76 | 45 | 60 | 44 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 77 | 72 | 41 | 57 | 39 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 212 | 169 | 110 | 92 | 71 |
Depreciation & Amortization (Cash Flow) | 58 | 40 | 29 | 21 | 19 |
Income After Depreciation & Amortization | 154 | 129 | 82 | 70 | 52 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 90.47 | 94.87 | 94.23 | 97.77 | 75.82 |
Diluted EPS Before Non-Recurring Items | 1.21 | 1.05 | 0.44 | 0.61 | 0.70 |
Diluted Net EPS (GAAP) | 0.86 | 0.80 | 0.44 | 0.61 | 0.51 |
Fiscal Year end for Afya Limited falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 155.17 | 162.38 | 147.26 | 148.17 | 143.95 |
Cost Of Goods | 60.32 | 54.41 | 58.17 | 59.03 | 57.43 |
Gross Profit | 94.85 | 107.96 | 89.09 | 89.14 | 86.52 |
SG&A, R&D, and Dept/Amort Expenses | 50.63 | 49.54 | 54.29 | 50.17 | 50.84 |
Income After SG&A, R&D, and Dept/Amort Expenses | 44.22 | 58.42 | 34.80 | 38.97 | 35.68 |
Non-Operating Income | 5.13 | 6.00 | 5.27 | 7.25 | 5.47 |
Interest Expense | 17.68 | 20.17 | 21.08 | 23.61 | 23.05 |
Pretax Income | 31.67 | 44.25 | 19.00 | 22.60 | 18.10 |
Income Taxes | 0.59 | 2.19 | -1.74 | 2.49 | 0.42 |
Minority Interest | 0.76 | 0.99 | 0.78 | 1.00 | 0.96 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 31.08 | 42.06 | 20.74 | 20.12 | 17.68 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 30.31 | 41.07 | 19.96 | 19.12 | 16.72 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 90.93 | 91.62 | 93.47 | 90.69 | 90.28 |
Diluted EPS Before Non-Recurring Items | 0.41 | 0.52 | 0.34 | 0.26 | 0.27 |
Diluted Net EPS (GAAP) | 0.33 | 0.45 | 0.22 | 0.21 | 0.19 |